Deanne Miller
Chief Operating Officer at IMMUTEP LIMITED
Net worth: 809 998 $ as of 31/03/2024
Profile
Deanne Miller is currently the Co-Managing Director at Immutep GmbH and the COO, Secretary & General Counsel at Immutep Ltd.
She is also a Member of The Law Society of New South Wales.
Previously, she worked as an Associate Director at Westpac Banking Corp., a Manager-Legal & Compliance at Macquarie Group Ltd., and a Legal Counsel at RBC Investor Services Trust (Australia).
Ms. Miller completed her undergraduate and graduate degrees at The University of Sydney.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUTEP LTD
0.27% | 22/08/2023 | 3,267,305 ( 0.27% ) | 809 998 $ | 31/03/2024 |
Deanne Miller active positions
| Companies | Position | Start |
|---|---|---|
| IMMUTEP LIMITED | Chief Operating Officer | 01/11/2016 |
| The Law Society of New South Wales | Corporate Officer/Principal | - |
Immutep GmbH
 Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The private company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Chief Executive Officer | - |
Former positions of Deanne Miller
| Companies | Position | End |
|---|---|---|
| MACQUARIE GROUP LIMITED | Compliance Officer | - |
| RBC Investor Services Trust (Australia) | General Counsel | - |
| WESTPAC BANKING CORPORATION | Corporate Officer/Principal | - |
Training of Deanne Miller
| The University of Sydney | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| WESTPAC BANKING CORPORATION | Finance |
| IMMUTEP LIMITED | Health Technology |
| MACQUARIE GROUP LIMITED | Finance |
| Private companies | 3 |
|---|---|
| The Law Society of New South Wales | |
| RBC Investor Services Trust (Australia) | Finance |
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The private company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Health Technology |
- Stock Market
- Insiders
- Deanne Miller
